SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q/A

(Amendment #2)

(Mark One)[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended
June 30, 2012

or

[ ] TRANSITION REPORT PURSUANT
TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from
_______________________to__________________________

Commission File Number: 000-54582

MySkin, Inc.
(Exact name of Registrant as specified in its charter)

|California(State or other jurisdiction of incorporation or organization) | 26-1391338(I.R.S. Employer Identification No.)
|------------------------------------------------------------------------ | ----------------------------------------------

410 32nd St.,
Suite 203, Newport Beach, CA 92663
(Address of principal executive offices - Zip Code)

(949) 209-8953
(Registrant's telephone number, including area code)

__________________________________________________________________
(Former name, former address and former fiscal year, if changed since last report)

Indicate by check mark whether the registrant (1)
has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12
months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing
requirements for the past 90 days.

Yes [X] No [ ]

Indicate by check mark whether the registrant is a
large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of
"large accelerated filer," "accelerated filer" and "smaller reporting company" in Rule 12b-2 of the
Exchange Act.

|Large accelerated filer [ ]                                            | Accelerated filer [ ]        
|---------------------------------------------------------------------- | -----------------------------
|Non-Accelerated filer [ ](Do not check if a smaller reporting company) | Smaller Reporting Company [X]

Indicate by check mark whether the registrant is a
shell company (as defined in Rule 12b-2 of the Exchange Act).

Yes [ ] No [X]

APPLICABLE ONLY TO CORPORATE ISSUERS:

Indicate the number of shares outstanding of each
of the issuer's classes of common stock, as of the latest practicable date.

On November 6, 2012, there were
1,505,000 shares of the issuer's common stock were outstanding.









Explanatory Note



This Amendment
No. 2 on Form 10-Q/A (the “Form 10-Q/A”) amends the Quarterly Report on Form 10-Q/A Amendment No. 1 for the
periods ended June 30, 2012 and 2011, filed by MySkin, Inc. (the “Company”), which was originally filed with the
Securities and Exchange Commission on November 2, 2012 (the “Original Report”).



We have amended
Item 4 to set forth that our disclosure controls and procedures and internal controls over financial reporting were not effective
for the three months ended June 30, 2012 and 2011. The Form 10-Q/A includes amended and restated financial statements and related
financial information for the three months ended June 30, 2012 and 2011. The nature, timing, and impact of the restatement and
the amended and restated financial results for the periods ended June 30, 2012 and 2011 is disclosed in Note 6 to the financial
statements



The Form 10-Q/A
amends and restates the following items of the Form 10-Q as described above: Part I, Item 4 – Controls and Procedures.



All information
in the Form 10-Q, as amended by the Form 10-Q/A Amendment No. 1, and as amended by Form 10-Q/A Amendment No. 2, speaks as to the
date of the original filing of the Form 10-Q for such period and does not reflect any subsequent information or events except as
noted in the Form 10-Q/A. all information contained in the Form 10-Q/A is subject to updating and supplementing as provided in
the Company’s reports, as amended, filed with the Securities and Exchange Commission subsequent to the date of the initial
filing of the Form 10-Q.



-2-







Item 4. Controls and Procedures.

Evaluation of Disclosure
Controls and Procedures: We conducted an evaluation under the supervision and with the participation of our management,
including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure
controls and procedures. The term "disclosure controls and procedures", as defined in Rules 13a-15(e) and 15d-15(e) under
the Securities and Exchange Act of 1934, as amended ("Exchange Act"), means controls and other procedures of a company
that are designed to ensure that information required to be disclosed by the company in the reports it files or submits under the
Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the Securities and Exchange
Commission's rules and forms. Disclosure controls and procedures also include, without limitation, controls and procedures designed
to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act
is accumulated and communicated to the company's management, including its principal executive and principal financial officers,
or persons performing similar functions, as appropriate, to allow timely decisions regarding required disclosure. Based on this
evaluation, our Chief Executive Officer and Chief Financial Officer concluded as of June 30, 2012, that our disclosure controls
and procedures are not effective to a reasonable assurance level of achieving such objectives. Specifically, our disclosure controls
procedures over the presentation for revenue related to our management fee and reimbursement of expenses had a material weakness
which resulted in a restatement of our statement of the period ended June 30, 2012. It should be noted that the design of any system
of controls is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that
any design will succeed in achieving its stated goals under all potential future conditions, regardless of how remote.

Management's Report on
Internal Control Over Financial Reporting: Our management is responsible for establishing and maintaining adequate internal
control over financial reporting as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act. Our internal control over
financial reporting is designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation
of financial statements for external purposes in accordance with generally accepted accounting principles. The internal controls
for the Company are provided by executive management's review and approval of all transactions. Our internal control over financial
reporting also includes those policies and procedures that:

1. Pertain to the maintenance of records
that in reasonable detail accurately and fairly reflect the transactions and dispositions of our assets;
2. Provide reasonable assurance that transactions
are recorded as necessary to permit preparation of financial statements in accordance with U.S. GAAP, and that our receipts and
expenditures are being made only in accordance with the authorization of our management; and
3. Provide reasonable assurance regarding
prevention or timely detection of unauthorized acquisition, use or disposition of our assets that could have a material effect
on the financial statements.

Because of its inherent limitations,
internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness
to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree
of compliance with the policies or procedures may deteriorate.

Management assessed the effectiveness
of the Company's internal control over financial reporting as of June 30, 2012. In making this assessment, management used the
criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission in Internal Control-Integrated Framework.
Management's assessment included an evaluation of the design of our internal control over financial reporting and testing of the
operational effectiveness of these controls.

Based on this assessment, management
has concluded that as of June 30, 2012, our internal control over financial reporting was not effective to provide reasonable assurance
regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance
with U.S. generally accepted accounting principles. Specifically, our internal controls over the presentation for revenue related
to our management fee and reimbursement of expenses had a material weakness which resulted in a restatement of our statement of
the period ended June 30, 2012.



-3-







This quarterly report does not
include an attestation report of the Company's registered public accounting firm regarding internal control over financial reporting.
Management's report was not subject to attestation by the Company's registered public accounting firm pursuant to temporary rules
of the Securities and Exchange Commission that permit the Company to provide only management's report in this annual report.

Changes in Internal Control
over Financial Reporting: There were no changes in our internal control over financial reporting during the third quarter
ending June 30, 2012, that have materially affected, or are reasonably likely to materially affect, our internal control over financial
reporting.

Item 6. Exhibits.

| |  | Exhibits
| |  | --------
| |  | 31      
| |  |         
| |  | 32      
| |  |         



-4-







SIGNATURES

In accordance with the requirements of the Exchange
Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

|                   | MYSKIN, INC.                                                                                               
|------------------ | -----------------------------------------------------------------------------------------------------------
|                   |                                                                                                            
|Date: May 17, 2013 | BY: /s/ Marichelle StoppenhagenMarichelle StoppenhagenChief Executive Officer                              
|                   |                                                                                                            
|Date: May 17, 2013 | BY: /s/ Marichelle StoppenhagenMarichelle StoppenhagenChief Financial Officer, Principal Accounting Officer



-5-